Sheng L. Tian
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].
Journal: European journal of medicinal chemistry
Published: July 03, 2026
Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation.
Journal: European journal of medicinal chemistry
Published: May 14, 2026
Uncovering a photoprotective polysaccharide from Gentiana dahurica via systematic fractionation.
Journal: Pharmaceutical science advances
Published: December 19, 2025
Discovery of Novel P2Y14R Inhibitors for Ameliorating Liver Fibrosis by Suppressing Hepatic Stellate Cell Activation.
Journal: Journal of medicinal chemistry
Published: November 03, 2025
Discovery of New N-H Aporphine Derivatives As Brain-Penetrant Gq-Biased 5-HT2C Receptor Agonists and Dual 5-HT2C/5-HT2A Receptor Agonists.
Journal: Journal of medicinal chemistry
Published: October 18, 2025
Allosteric Cooperativity Mechanism Investigation of Orthosteric and Allosteric Ligands in Modulating AR Activity: A Molecular Dynamics Study.
Journal: Journal of chemical information and modeling
Published: October 13, 2025
Machine Learning Applied in Small Molecule Drug Discovery: Models, Strategies, and Future Prospects.
Machine Learning Applied in Small Molecule Drug Discovery: Models, Strategies, and Future Prospects.
Journal: Current topics in medicinal chemistry
Published: July 17, 2025
SO2 Gas Sensing by Nanometer-Thick Soap Films Using Conductometry and Fluorimetry.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: June 05, 2025
Computational discovery and repurposing of chloramphenicol succinate as a potent P2Y14 receptor antagonist for inflammatory bowel disease therapy.
Journal: Journal of advanced research
Published: April 20, 2025
P2Y12R antagonists in antithrombotic therapy: a patent and literature review (2019-present).
Journal: Expert opinion on therapeutic patents
Published: February 14, 2025
Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development.
Journal: Acta pharmaceutica Sinica. B
Published: January 05, 2025
Last Updated: 09/26/2026